Atlas Trials

ITM Solucin GmbH

4 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch ITM Solucin GmbH

RecordFirmDate
Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors (NCT06441331)ITM Solucin GmbH2025-09-26
Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSE (NCT04919226)ITM Solucin GmbH2021-12-21

Track ITM Solucin GmbH automatically

Every clearance here is in the API, with alerts when new ones post.